|
Volumn 111, Issue 6, 2016, Pages 903-905
|
Direct observed therapy of chronic Hepatitis C with interferon-free all-oral regimens at a low-threshold drug treatment facility - A new concept for treatment of patients with borderline compliance receiving opioid substitution therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLATASVIR;
LEDIPASVIR;
PEGINTERFERON;
RIBAVIRIN;
SOFOSBUVIR;
ANTIVIRUS AGENT;
BENZIMIDAZOLE DERIVATIVE;
BMS-790052;
FLUORENE DERIVATIVE;
IMIDAZOLE DERIVATIVE;
ANTIVIRAL THERAPY;
CHRONIC HEPATITIS C;
COMORBIDITY;
COMPENSATED LIVER CIRRHOSIS;
ELASTOGRAPHY;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
LETTER;
OPIATE SUBSTITUTION TREATMENT;
PATIENT COMPLIANCE;
PHYSICIAN;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
REIMBURSEMENT;
TREATMENT DURATION;
TREATMENT OUTCOME;
ADULT;
COMBINATION DRUG THERAPY;
COMPLICATION;
DIAGNOSTIC IMAGING;
DIRECTLY OBSERVED THERAPY;
DRUG DEPENDENCE TREATMENT;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER CIRRHOSIS;
MALE;
MEDICATION COMPLIANCE;
MIDDLE AGED;
MIXED INFECTION;
OPIATE ADDICTION;
PROCEDURES;
SEVERITY OF ILLNESS INDEX;
ADULT;
ANTIVIRAL AGENTS;
BENZIMIDAZOLES;
COINFECTION;
DIRECTLY OBSERVED THERAPY;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUORENES;
HEPATITIS C, CHRONIC;
HIV INFECTIONS;
HUMANS;
IMIDAZOLES;
LIVER CIRRHOSIS;
MALE;
MEDICATION ADHERENCE;
MIDDLE AGED;
OPIATE SUBSTITUTION TREATMENT;
OPIOID-RELATED DISORDERS;
SEVERITY OF ILLNESS INDEX;
SOFOSBUVIR;
SUBSTANCE ABUSE TREATMENT CENTERS;
|
EID: 84973320180
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2016.119 Document Type: Letter |
Times cited : (24)
|
References (5)
|